Speakers:
Contingent value rights (CVRs) represent an increasingly prominent part of the M&A landscape in the life sciences industry. Please join Ropes & Gray attorneys Paul Kinsella and Marko Zatylny as they discuss the use of CVRs to address uncertainties inherent in the development and commercialization of pharmaceutical products, bridge valuation gaps, and facilitate negotiations. They also will provide an overview of the common CVR features and legal and contractual issues arising out of the use of CVRs.
Ropes & Gray Speakers
Stay Up To Date with Ropes & Gray
Subscribe to Our Podcast
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Follow Us on Social
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
Join Our Mailing List
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.